chenodeoxycholic acid has been researched along with letrozole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| He, Y; Huang, QF; Li, ZW; Tang, WL; Wang, ZW; Wu, S; Yang, YL; Zhou, HW; Zhou, WW; Zhou, ZY | 1 |
1 review(s) available for chenodeoxycholic acid and letrozole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for chenodeoxycholic acid and letrozole
| Article | Year |
|---|---|
Intestinal Flora is a Key Factor in Insulin Resistance and Contributes to the Development of Polycystic Ovary Syndrome.
Topics: Animals; Bacteroides; Biomarkers; Case-Control Studies; Chenodeoxycholic Acid; Female; Fibroblast Growth Factors; Gastrointestinal Microbiome; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Letrozole; Metabolomics; Mice; Mice, Inbred C57BL; Phenotype; Polycystic Ovary Syndrome; Receptors, Cytoplasmic and Nuclear; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2021 |